Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 740-750
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.740
Table 1 Cohort demographics (n = 139)

Total (n = 139)
Mean age (years, SD)39.1 (17.1)
Female, n (%)66 (47.5)
European Ancestry, n (%)121 (88.3)
Mean disease duration, (months, SD)151.8 (136.3)
Mean body mass index (kg/m2, SD)23.3 (4.8)
Active smoking, n (%)6 (4.4)
Disease location, n (%)
   Ileal (L1)61 (43.9)
   Ileocolonic (L3)78 (56.1)
   Upper GI (L4)12 (8.6)
Disease behavior, n (%)
   Non-fibrostenosing, non-penetrating (B1)7 (5.1)
   Fibrostenosing (B2)54 (39.2)
   Internal penetrating (B3)35 (25.4)
   Stricturing and internal penetrating (B2/3)42 (30.4)
Perianal disease, n (%)23 (16.5)
Pre-operative medication, n (%)
   None33 (23.7)
   Corticosteroid48 (34.5)
   5-aminosalicylic acid21 (15.1)
   Immunomodulator32 (23.0)
   Biologic73 (52.5)
Prior surgery, n (%)39 (28.1)
Post-operative prophylaxis, n (%)120 (86.3)
   5-aminosalicylic acid7 (5.8)
   Immunomodulator23 (19.2)
   Biologic94 (78.3)

  • Citation: Gu P, Dube S, Gellada N, Choi SY, Win S, Lee YJ, Yang S, Haritunians T, Melmed GY, Vasiliauskas EA, Bonthala N, Syal G, Yarur AJ, Ziring D, Rabizadeh S, Fleshner P, Kallman C, Devkota S, Targan SR, Li D, McGovern DP. Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn’s disease. World J Gastrointest Surg 2024; 16(3): 740-750
  • URL: https://www.wjgnet.com/1948-9366/full/v16/i3/740.htm
  • DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.740